FENOMA Study: Achieving Full Control in Patients with Severe Allergic Asthma.

Sheila CabrejosAna MoreiraAndreina RamirezSantiago Quirce Gregorio Soto Campos Ignacio Dávila GonzálezPaloma Campo

Published in: Journal of asthma and allergy (2020)

This study highlights the asthma control achieved by patients with severe allergic asthma treated with omalizumab, with relevant benefits on the burden of the disease both on patients and the healthcare system.

Keyphrases

allergic rhinitis
chronic obstructive pulmonary disease
lung function
newly diagnosed
ejection fraction
cystic fibrosis